AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

HELIOS UNDERWRITING PLC

Board/Management Information Jul 9, 2013

7691_rns_2013-07-09_aef6f9d9-cdb3-43ec-9e67-ff7dfd5cc1a8.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8453I

Hampden Underwriting Plc

09 July 2013

9 July 2013

Hampden Underwriting plc

("Hampden Underwriting" or the "Company")

Appointment of non-executive director

Hampden Underwriting plc, which provides investors with a limited liability direct investment into the Lloyd's insurance market, is pleased to announce the appointment of Andrew Christie as a non-executive director of the Company with immediate effect.  Andrew is a founding partner of corporate finance advisory firm, Smith Square Partners and has nearly 30 years' experience in corporate finance.  Prior to Smith Square Partners, he was a Managing Director in the Investment Banking Division of Credit Suisse Europe and prior to that he was head of investment banking in Asia Pacific for Credit Suisse First Boston and Barclays de Zoete Wedd.  Andrew is a non-executive director of FTSE 250 company, Elementis plc.

Sir Michael Oliver, Chairman of Hampden Underwriting, said:

"We are delighted to welcome Andrew to the Hampden board and look forward to the benefit of his experience as the development of the Company continues."

For further information please contact:

Hampden Underwriting Nigel Hanbury [email protected]
Smith & Williamson Corporate Finance David Jones 020 7131 4000

Additional information

Andrew Hildred Christie (aged 57) is currently a director/partner of the following companies/partnerships: Smith Square Partners LLP; Elementis plc; Tedworth North Management Limited; Tedworth Square North Limited; Nomina No 174 LLP; Nomina No 371 LLP; Conservation Education & Research Trust, and has been a director of the following companies in the last five years: Ark Therapeutics Group plc.

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAUGUMPMUPWGAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.